Diabex XR 1000 metformin hydrochloride

Diabex is a widely recognized brand of metformin hydrochloride, a medication primarily used for the treatment of type 2 diabetes. The brand particularly caters to the Australian and Oceanic markets. It was originally developed by Alphapharm, which became a significant player in the Australian generic medicine sector. Alphapharm was later acquired by the global pharmaceutical giant Mylan.

Following the 2020 merger between Mylan and Pfizer's Upjohn division, the brand became part of the Viatris Inc. portfolio. Viatris is an American global healthcare company that manages a vast array of established brands and generic medicines. While the brand has deep Australian roots, manufacturing is conducted across various global facilities certified by health authorities to meet quality standards for different regional markets. The specific product shown, Diabex XR 1000, features an extended-release formulation designed for once-daily dosing.